Miami Physician Dr. Alonso Martin Addresses Public Safety Risks Following Report of Illegal Botox Injections in Brickell

Dr. Martin discusses how counterfeit neurotoxins and non-medical providers can lead to preventable complications and long-term harm.

MIAMI, FL / ACCESS Newswire / December 23, 2025 / A recent televised investigation from Telemundo 51 has brought renewed attention to the growing dangers associated with unlicensed cosmetic injectors and the circulation of unauthorized neurotoxin products in South Florida. The case, which centers on an individual accused of administering cosmetic injections without a medical license in a Brickell office tower, reflects a broader trend that medical professionals in the region- including Dr. Alonso Martin of BODYWELLE - have been increasingly concerned about.

Authorities reported that 39-year-old Yung Yung Mustafa was arrested after allegedly offering neurotoxin injections under the guise of a medical provider. According to the Miami-Dade Police Department's Medical Crimes Squad and the Florida Department of Health, the individual promoted cosmetic services through his business, YM Aesthetics LLC, despite lacking proper licensure. When an undercover agent visited the office, Mustafa allegedly discussed the procedure, presented the injectable product, and agreed to administer treatment for $599. Officers later confirmed that the vial shown to the agent contained Rentox-a product imported from South Korea that is not approved for use in the United States and requires a prescription.

The full televised report, which aired December 4, is available here: Click to watch video.

Dr. Martin participated in the broadcast to help contextualize how unregulated neurotoxins and unlicensed providers increase the risk of complications. His interview focused on the escalating frequency of these cases and on why medically supervised treatment remains essential to patient safety.

A Growing Public Health Concern in Miami's Aesthetic Landscape

South Florida is one of the country's largest hubs for aesthetic procedures, ranging from Botox to dermal fillers and other minimally invasive treatments. While the demand for cosmetic enhancements continues to rise, so too has the number of unregulated operators offering services outside the medical system.

The problem extends beyond licensure. As Dr. Martin noted in the televised segment, providers without medical credentials cannot legally purchase authentic prescription neurotoxins in the United States. Pharmaceutical manufacturers such as AbbVie and Galderma require valid state medical licensing and formal registration before distributing their products. Without access to legitimate supply chains, unlicensed individuals often turn to foreign or counterfeit neurotoxins with unknown potency, purity, and formulation.

This increase in unregulated activity places the public at heightened risk. The mission of BODYWELLE emphasizes individualized care grounded in safety, clinical oversight, and patient-specific decision-making; incidents like the Brickell case illustrate why these standards are essential across the field.

Why Unauthorized Neurotoxins Pose Significant Medical Risks

Botulinum toxin, when FDA-approved and administered correctly, temporarily relaxes targeted facial muscles by disrupting nerve signaling. The effectiveness and safety of treatment depend on precise dosing, standardized manufacturing, and clinician familiarity with neuromuscular function.

Unregulated or counterfeit products, however, bypass these safeguards. Products like Rentox-which authorities reported in this case-have not undergone U.S. review for potency, sterility, dilution accuracy, or biological behavior. Even slight variations in concentration can produce unintended neuromuscular effects.

In clinical terms, unapproved neurotoxins may lead to:

• Excessive or prolonged muscle paralysis

• Brow or eyelid ptosis

• Asymmetrical facial movement

• Unexpected diffusion into unintended muscles

• Local inflammatory reactions or systemic responses

These complications occur because neurotoxins rely on consistent molecular behavior. When a substance has been manufactured outside of regulated pharmaceutical standards, its clinical effects become unpredictable.

This is why Dr. Martin noted in the broadcast that unlicensed individuals do not have access to authentic prescription neurotoxins, since obtaining them requires medical licensure and registration with pharmaceutical manufacturers. BODYWELLE's patient-focused framework emphasizes medically supervised decision-making to help prevent such errors and ensure that each treatment is tailored to an individual's goals, symptoms, recovery requirements, and lifestyle.

Importance of Anatomical Knowledge and Medical Licensing

Beyond product safety, the incident highlights the critical importance of anatomical, procedural, and emergency-management training for anyone performing injectable treatments. Facial anatomy is complex; subtle differences in muscle origin, insertion, and thickness influence dosing and injection depth. Even experienced clinicians adjust their techniques based on a patient's unique muscular patterns.

Unlicensed individuals typically do not have formal training in:

• Facial vascular and muscular anatomy

• Neurotoxin pharmacology

• Complication mitigation

• Medical aseptic protocol

• Dose-response relationships

• Safe injection planes

This knowledge forms the basis for predictable outcomes. It also enables providers to intervene appropriately if an adverse reaction occurs. When treatments are performed by unlicensed injectors, patients lose access to the safety framework that legitimate medical care provides.

At BODYWELLE, Dr. Martin evaluates each patient's anatomy and goals, using medical history, functional patterns, and full clinical context to determine whether neuromodulators or fillers are appropriate. This physician-led approach reflects a broader commitment to safety and individualized care-important values to emphasize in light of increasing reports of improper practice across the region.

Identifying Legitimate Medical Injectors

Florida residents can verify a provider's credentials through the Florida Department of Health's license lookup system, which lists the status of medical professionals. National professional organizations such as the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), American Society of Plastic Surgeons (ASPS), and American Board of Medical Specialties (ABMS) provide additional guidance for evaluating qualified injectors.

Patients seeking cosmetic injections can take several steps to protect themselves:

1. Confirm active medical licensure for the provider administering treatment.

2. Ensure products are purchased directly from U.S. manufacturers-not third-party resellers or international distributors.

3. Request information about the product being used, including brand, lot number, and expiration date.

4. Evaluate whether the setting is a medical office, not a rented suite, pop-up space, or salon.

5. Ensure clear aftercare and follow-up plans are provided.

6. Be cautious of unusually low pricing, which often signals counterfeit or unauthorized products.

BODYWELLE encourages patients to prioritize regulated environments where treatment decisions are guided by medical oversight and tailored to long-term health, safety, and aesthetic outcomes.

A Community-Wide Need for Awareness

The Brickell case illustrates how the aesthetic marketplace has expanded beyond traditional medical practices, creating opportunities for unlicensed individuals to present themselves as trained injectors. These situations place the public at unnecessary risk and often emerge only after a patient experiences complications-or, as in this case, when an undercover investigation reveals unauthorized activity.

Dr. Martin's participation in the Telemundo report reflects a broader physician-led effort to educate the public and reduce preventable harm. His focus on authentic product sourcing, regulated clinical environments, and anatomical expertise highlights the essential components of safe injectable care.

Patients seeking more information or wishing to schedule a consultation in a medically supervised setting may visit BODYWELLE online at alonsomartinmd.com or reach the practice directly through the contact page.

Media Contact
Dr. Alonso Martin
info@alonsomartinmd.com
(305) 877-5084

SOURCE: BODYWELLE